NET PROFIT (x1000 SEK)
EMPLOYEES
Pharmnovo AB
Closing information (x1000 SEK)
Closing information | 2023/12 | 2022/06 | 2021/06 |
Turnover |
0
![]() |
0
![]() |
0 |
Financial expenses |
1,411
|
109
|
0 |
Earnings before taxes |
-68,852
|
-26,556
|
-13,255 |
EBITDA |
-67,534
|
-26,409
|
-13,218 |
Total assets |
24,109
|
27,037
|
9,999 |
Current assets |
24,021
|
26,918
|
9,843 |
Current liabilities |
3,482
|
2,602
|
2,723 |
Equity capital |
20,583
|
24,391
|
7,227 |
- share capital |
414
|
342
|
212 |
Employees (average) |
3
|
1
![]() |
1 |
Financial ratios
Fiscal year | 2023/12 | 2022/06 | 2021/06 |
Solvency |
85.4%
|
90.2%
|
72.3% |
Turnover per employee |
0
![]() |
0
![]() |
0 |
Profit as a percentage of turnover | |||
Return on assets (ROA) |
-279.7%
|
-97.8%
|
-132.6% |
Current ratio |
689.9%
|
1034.5%
|
361.5% |
Return on equity (ROE) |
-334.5%
|
-108.9%
|
-183.4% |
Change turnover |
0
![]() |
0
![]() |
0 |
Change turnover % | |||
Chg. No. of employees |
2
|
0
![]() |
0 |
Chg. No. of employees % |
200%
|
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/06 | 2021/06 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.